TSX News -
UEX Vests 60% Interest in Christie Lake
SASKATOON, Saskatchewan, Nov. 29, 2018 (GLOBE NEWSWIRE) — UEX Corporation (UEX:TSX) (“UEX” or the “Company”) is pleased to announce that […]
Fura Provides Update on Ruby Transactions in Mozambique
Key Highlights The purchase consideration for the Mustang Ruby Assets in Mozambique is reduced to A$2,800,000 from A$9,999,999 of Fura […]
Solar Alliance Strategic Investor Increases Shareholding and Commits to Funding Future Growth
VANCOUVER, British Columbia and KNOXVILLE, Tenn., Nov. 29, 2018 (GLOBE NEWSWIRE) — Solar Alliance Energy Inc. (‘Solar Alliance’ or the […]
James E. Wagner Cultivation Corporation Licenses its Proprietary GrowthSTORM™ System to Affiliate Cannabis Producer
KITCHENER, Ontario, Nov. 29, 2018 (GLOBE NEWSWIRE) — James E. Wagner Cultivation Corporation (“JWC” or the “Corporation”) (TSX VENTURE: JWCA), […]
SugarBud Announces Q3 2018 Financial and Operating Results
TSX-Venture Exchange: SUGR, SUGR.WT CALGARY, Alberta, Nov. 29, 2018 (GLOBE NEWSWIRE) — SugarBud Craft Growers Corp. (“SugarBud”) is pleased to […]
Titan Machinery Inc. Announces Results for Fiscal Third Quarter Ended October 31, 2018
– Revenue for Third Quarter of Fiscal 2019 Increased 10.1% to $364 million – – EPS for the Third Quarter […]
TSX News -
National Airlines Streamlines Worldwide Mail Transportation with Descartes Velocity Mail Solution
WATERLOO, Ontario, Nov. 29, 2018 (GLOBE NEWSWIRE) — Descartes Systems Group (Nasdaq:DSGX) (TSX:DSG), the global leader in uniting logistics-intensive businesses […]
QMX Gold Upsizes and Closes Previously Announced Non-Brokered Private Placement at $1.8 Million
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES (All figures in Canadian dollars […]
Postbank Customers Get Improved Access to Their Cash through Cardtronics ATMs
TRIER, Germany, Nov. 29, 2018 (GLOBE NEWSWIRE) — Approximately 13 million Postbank customers will now have free-of-charge access to Cardtronics […]
FDA Approves Firdapse® (amifampridine) for the Treatment of Lambert-Eaton Myasthenic Syndrome (LEMS)
– First evidenced-based medicine approved to treat LEMS – Catalyst Pathways™ designed to facilitate access to Firdapse® and provide dedicated […]
